Post by
SmartPodhotzone on Dec 19, 2020 6:57pm
Here comes another dilutive scam deal
Antibe Therapeutics Inc. has commenced preliminary discussions to amalgamate Antibe Holdings Inc. with the company in order to unify the intellectual property (IP) ownership of the company's drugs and platform. The Company believes that such an initiative would unlock value for potential partners and investors while simplifying IP protection for pipeline expansion efforts now underway. "As described in our ongoing disclosures, the Company was founded with an exclusive license from Holdings," commented Dan Legault, Antibe's CEO. "Based on this IP, we have achieved human proof-of-concept for otenaproxesul and developed compelling preclinical data for our other pipeline drugs. As we map out strategic initiatives with prospective partners and healthcare-specialized investors, we expect full ownership of the underlying IP to strengthen our corporate position. It also represents another step in our growth strategy, complementing our recent graduation to the TSX, share consolidation and the appointment of U.S.-based directors." The Company will update the market upon further material developments as they are achieved. About Antibe Therapeutics Inc
Comment by
bringon10bagger on Dec 19, 2020 9:03pm
Hey Smartie, what cloud did you just fall off.......
Comment by
Qtrlbder on Dec 19, 2020 9:40pm
Buddy, if you want to bash, at least do it properly. Next time give more content instead of copy and paste a nr. What a joke....!